Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E F Foote

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 15, 1995
Prevention and treatment of diabetic nephropathyE F Foote
The Annals of Pharmacotherapy|February 1, 1995
Calcium-channel blockers for prophylaxis of radiocontrast-associated nephrotoxicityC Seyss, E F Foote
Antimicrobial Agents and Chemotherapy|April 4, 1998
Effects of probenecid and cimetidine on renal disposition of ofloxacin in ratsE F Foote, C E Halstenson
ANNA Journal|December 11, 1997
Pulse dose oral calcitriol therapy for renal osteodystrophy: literature review and practice recommendationsN V Dahl, E F Foote
The Annals of Pharmacotherapy|December 1, 1993
New therapeutic agents in the management of hypertension: angiotensin II-receptor antagonists and renin inhibitorsE F Foote, C E Halstenson
Pharmacotherapy|July 1, 1996
Sertraline-associated syndrome of inappropriate antidiuretic hormone: case report and review of the literatureM E Bradley, E F Foote, E N Lee, et al.
Pediatrics|March 4, 2000
Predicting first-year relapses in children with nephrotic syndromeA R Constantinescu, H B Shah, E F Foote, et al.
The Annals of Pharmacotherapy|June 14, 2000
Nephrology pharmaceutical care preceptorship: a programmatic and clinical outcomes assessmentG R Matzke, W L St Peter, T J Comstock, et al.
Journal of Clinical Pharmacology|April 1, 1995
Disposition of misoprostol and its active metabolite in patients with normal and impaired renal functionE F Foote, D R Lee, A Karim, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1995
The pharmacokinetics of aminoguanidine in end-stage renal disease patients on hemodialysisE F Foote, Z M Look, P Giles, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 15, 1995
Prevention and treatment of diabetic nephropathyE F Foote
The Annals of Pharmacotherapy|February 1, 1995
Calcium-channel blockers for prophylaxis of radiocontrast-associated nephrotoxicityC Seyss, E F Foote
Antimicrobial Agents and Chemotherapy|April 4, 1998
Effects of probenecid and cimetidine on renal disposition of ofloxacin in ratsE F Foote, C E Halstenson
ANNA Journal|December 11, 1997
Pulse dose oral calcitriol therapy for renal osteodystrophy: literature review and practice recommendationsN V Dahl, E F Foote
The Annals of Pharmacotherapy|December 1, 1993
New therapeutic agents in the management of hypertension: angiotensin II-receptor antagonists and renin inhibitorsE F Foote, C E Halstenson
Pharmacotherapy|July 1, 1996
Sertraline-associated syndrome of inappropriate antidiuretic hormone: case report and review of the literatureM E Bradley, E F Foote, E N Lee, et al.
Pediatrics|March 4, 2000
Predicting first-year relapses in children with nephrotic syndromeA R Constantinescu, H B Shah, E F Foote, et al.
The Annals of Pharmacotherapy|June 14, 2000
Nephrology pharmaceutical care preceptorship: a programmatic and clinical outcomes assessmentG R Matzke, W L St Peter, T J Comstock, et al.
Journal of Clinical Pharmacology|April 1, 1995
Disposition of misoprostol and its active metabolite in patients with normal and impaired renal functionE F Foote, D R Lee, A Karim, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1995
The pharmacokinetics of aminoguanidine in end-stage renal disease patients on hemodialysisE F Foote, Z M Look, P Giles, et al.
Pageof 2